These results may point at a reassortment in the functional group of activated-signalling, shifted towards FLT3-ITD, supporting the suggestion, that RUNX1 mutation preferably contributes to leukaemogenesis by cooperating with the activating FLT3-ITD, instead of other activating pathways in paediatric AML. Here, RUNX1 is linked to acute myeloid leukemia.